ENSG:NGS-The Ensign Group Inc. (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 145.43

Change

-0.58 (-0.40)%

Market Cap

USD 1.10B

Volume

0.38M

Analyst Target

USD 62.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ensign Group Inc offers skilled nursing & rehabilitative care services in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Oregon, Texas & Washington.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-30 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ACHC Acadia Healthcare Company Inc

N/A

USD 7.10B
OPCH Option Care Health Inc

N/A

USD 5.48B
SGRY Surgery Partners Inc

N/A

USD 3.93B
AMED Amedisys Inc

N/A

USD 3.18B
LFST Lifestance Health Group Inc

N/A

USD 2.41B
ADUS Addus HomeCare Corporation

N/A

USD 2.29B
ASTH Astrana Health Inc

N/A

USD 2.17B
AVAH Aveanna Healthcare Holdings In..

N/A

USD 1.05B
HCSG Healthcare Services Group Inc

N/A

USD 0.79B
CCRN Cross Country Healthcare Inc

N/A

USD 0.51B

ETFs Containing ENSG

PSCH Invesco S&P SmallCap Heal.. 6.06 % 0.29 %

N/A

USD 0.20B
OSCV 2.83 % 0.79 %

N/A

N/A
XHS SPDR® S&P Health Care Se.. 2.53 % 0.35 %

N/A

USD 0.09B
XSMO Invesco S&P SmallCap Mome.. 2.11 % 0.39 %

N/A

USD 1.24B
VIOG Vanguard S&P Small-Cap 60.. 1.15 % 0.20 %

N/A

USD 0.99B
ESIX SPDR S&P SmallCap 600 ESG.. 1.00 % 0.00 %

N/A

USD 5.50M
XSLV Invesco S&P SmallCap Low .. 1.00 % 0.25 %

N/A

USD 0.35B
OASC OneAscent Small Cap Core .. 0.97 % 0.00 %

N/A

N/A
MWON:XETRA Amundi S&P SmallCap 600 E.. 0.91 % 0.00 %

N/A

USD 0.14B
USASUS:SW Amundi S&P SmallCap 600 E.. 0.91 % 0.00 %

N/A

USD 0.14B
CBUSAS:SW Amundi S&P SmallCap 600 E.. 0.85 % 0.00 %

N/A

N/A
SPSM SPDR® Portfolio S&P 600 .. 0.67 % 0.06 %

N/A

USD 11.12B
ZSML-F:CA BMO S&P US Small Cap Inde.. 0.61 % 0.00 %

N/A

CAD 5.46M
ZSML-U:CA BMO S&P US Small Cap Inde.. 0.61 % 0.00 %

N/A

N/A
IDP6:SW iShares S&P SmallCap 600 .. 0.60 % 0.00 %

N/A

USD 1.90B
VTWG Vanguard Russell 2000 Gro.. 0.57 % 0.20 %

N/A

USD 0.96B
SAA ProShares Ultra SmallCap6.. 0.46 % 0.95 %

N/A

USD 0.04B
JPSE JPMorgan Diversified Retu.. 0.36 % 0.29 %

N/A

USD 0.52B
VTWO Vanguard Russell 2000 Ind.. 0.28 % 0.15 %

N/A

USD 9.91B
UWM ProShares Ultra Russell20.. 0.23 % 0.95 %

N/A

USD 0.30B
URTY ProShares UltraPro Russel.. 0.20 % 0.95 %

N/A

USD 0.41B
FNY First Trust Mid Cap Growt.. 0.00 % 0.70 %

N/A

USD 0.35B
HDG ProShares Hedge Replicati.. 0.00 % 0.95 %

N/A

USD 0.03B
IJR iShares Core S&P Small-Ca.. 0.00 % 0.07 %

N/A

USD 86.79B
IJT iShares S&P Small-Cap 600.. 0.00 % 0.25 %

N/A

USD 6.48B
IWO iShares Russell 2000 Grow.. 0.00 % 0.24 %

N/A

N/A
USVM VictoryShares US Small Mi.. 0.00 % 0.25 %

N/A

USD 0.26B
OLD 0.00 % 0.50 %

N/A

N/A
KSCD 0.00 % 0.00 %

N/A

N/A
VRTGX Vanguard Russell 2000 Gro.. 0.00 % 0.00 %

N/A

USD 1.19B
VRTIX Vanguard Russell 2000 Ind.. 0.00 % 0.00 %

N/A

USD 10.02B
SLY 0.00 % 0.15 %

N/A

N/A
SLYG SPDR® S&P 600 Small Cap .. 0.00 % 0.15 %

N/A

N/A
VIOO Vanguard S&P Small-Cap 60.. 0.00 % 0.15 %

N/A

N/A
IDP6:LSE iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

N/A
ISP6:LSE iShares III Public Limite.. 0.00 % 0.00 %

N/A

USD 1.97B
R2SC:LSE SPDR® Russell 2000 US Sm.. 0.00 % 0.00 %

N/A

USD 3.30B
R2US:LSE SPDR® Russell 2000 US Sm.. 0.00 % 0.00 %

N/A

USD 3.30B
RTWO:LSE L&G Russell 2000 US Small.. 0.00 % 0.00 %

N/A

USD 0.14B
RTWP:LSE Legal & General UCITS ETF.. 0.00 % 0.00 %

N/A

USD 0.14B
XRSG:LSE Xtrackers Russell 2000 UC.. 0.00 % 0.00 %

N/A

USD 1.37B
XRSU:LSE Xtrackers Russell 2000 UC.. 0.00 % 0.00 %

N/A

USD 1.37B
IUS3:F iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

N/A
2B77:XETRA iShares Ageing Population.. 0.00 % 0.00 %

N/A

USD 0.50B
ETLZ:XETRA L&G Russell 2000 US Small.. 0.00 % 0.00 %

N/A

USD 0.09B
IUS3:XETRA iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

N/A
ZSML:CA BMO S&P US Small Cap Inde.. 0.00 % 0.00 %

N/A

N/A
SMLE 0.00 % 0.00 %

N/A

N/A
DFAS Dimensional U.S. Small Ca.. 0.00 % 0.00 %

N/A

USD 8.80B
QVMS Invesco Exchange-Traded F.. 0.00 % 0.00 %

N/A

USD 0.20B
2B77:F iShares Ageing Population.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 29.61% 81% B- 86% B+
Dividend Return 0.11% 100% F 2% F
Total Return 29.71% 81% B- 86% B+
Trailing 12 Months  
Capital Gain 53.57% 92% A 90% A-
Dividend Return 0.25% 100% F 2% F
Total Return 53.82% 92% A 90% A-
Trailing 5 Years  
Capital Gain 149.58% 80% B- 89% A-
Dividend Return 1.87% 50% F 6% D-
Total Return 151.45% 80% B- 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 30.99% 77% C+ 85% B
Dividend Return 31.31% 77% C+ 85% B
Total Return 0.32% 50% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 39.13% 58% F 45% F
Risk Adjusted Return 80.02% 96% N/A 91% A-
Market Capitalization 1.10B 100% F 91% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.30 47% 27%
Price/Book Ratio 4.55 10% 24%
Price / Cash Flow Ratio 20.54 18% 15%
Price/Free Cash Flow Ratio 23.03 23% 11%
Management Effectiveness  
Return on Equity 15.08% 96% 85%
Return on Invested Capital 12.65% 89% 82%
Return on Assets 4.02% 54% 82%
Debt to Equity Ratio 9.75% 67% 72%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.